Rémi Spagnol

Investment Director

RÉMI HAS MORE THAN 7 YEARS OF EXPERIENCE IN PRIVATE EQUITY, HE JOINED THE TEAM IN 2021 AND IS RESPONSIBLE FOR THE HEALTHCARE SECTOR.

Rémi has conducted a career in different funds specializing in Life Sciences where he has been involved in numerous Late-Stage investments in France and internationally, such as Poxel, Corvidia Therapeutics and Arvelle Therapeutics. A Venture Capital investor at Omnes Capital then at Andera Partners until 2019, he was more recently a structured debt investor at IPF Partners.

Rémi graduated from the Faculty of Pharmacy, University of Paris-Saclay (PharmD) and holds a Specialized Master in Management of the Biopharmaceutical Industry from ESCP Europe (MS).

remi.spagnol@supernovainvest.com